Business Description
Quest Laboratories Ltd
ISIN : INE0TNW01017
Description
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | 0.48 | |||||
| Debt-to-Equity | 0.18 | |||||
| Debt-to-EBITDA | 0.8 | |||||
| Interest Coverage | 14.54 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 5.35 | |||||
| Beneish M-Score | -1.35 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 39.6 | |||||
| 3-Year EBITDA Growth Rate | 120.5 | |||||
| 3-Year EPS without NRI Growth Rate | 140.3 | |||||
| 3-Year Book Growth Rate | 69.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.83 | |||||
| 9-Day RSI | 43.28 | |||||
| 14-Day RSI | 47.37 | |||||
| 6-1 Month Momentum % | -12.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.45 | |||||
| Quick Ratio | 0.89 | |||||
| Cash Ratio | 0.01 | |||||
| Days Inventory | 158.52 | |||||
| Days Sales Outstanding | 260.14 | |||||
| Days Payable | 339.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.4 | |||||
| Operating Margin % | 14.37 | |||||
| Net Margin % | 9.24 | |||||
| FCF Margin % | 4.99 | |||||
| ROE % | 16.83 | |||||
| ROA % | 6.57 | |||||
| ROIC % | 13.03 | |||||
| ROC (Joel Greenblatt) % | 25.99 | |||||
| ROCE % | 23.99 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 45.34 | |||||
| PE Ratio without NRI | 45.21 | |||||
| PS Ratio | 4.19 | |||||
| PB Ratio | 6.08 | |||||
| Price-to-Tangible-Book | 6.13 | |||||
| Price-to-Free-Cash-Flow | 83.94 | |||||
| Price-to-Operating-Cash-Flow | 57.74 | |||||
| EV-to-EBIT | 29.78 | |||||
| EV-to-EBITDA | 28.55 | |||||
| EV-to-Revenue | 4.35 | |||||
| EV-to-FCF | 93.75 | |||||
| Price-to-Graham-Number | 3.52 | |||||
| Price-to-Net-Current-Asset-Value | 15.99 | |||||
| Earnings Yield (Greenblatt) % | 3.36 | |||||
| FCF Yield % | 1.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Quest Laboratories Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 415.457 | ||
| EPS (TTM) (₹) | 2.343 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 47.37 | ||
| 14-Day ATR (₹) | 5.051285 | ||
| 20-Day SMA (₹) | 109.45 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (₹) | 85.1 - 196.8 | ||
| Shares Outstanding (Mil) | 16.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Quest Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Quest Laboratories Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Quest Laboratories Ltd Frequently Asked Questions
What is Quest Laboratories Ltd(NSE:QUESTLAB)'s stock price today?
The current price of NSE:QUESTLAB is ₹107.10. The 52 week high of NSE:QUESTLAB is ₹196.80 and 52 week low is ₹85.10.
When is next earnings date of Quest Laboratories Ltd(NSE:QUESTLAB)?
The next earnings date of Quest Laboratories Ltd(NSE:QUESTLAB) is .
Does Quest Laboratories Ltd(NSE:QUESTLAB) pay dividends? If so, how much?
Quest Laboratories Ltd(NSE:QUESTLAB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers